1
|
Tate J, Stinstra J, Pilcher T, Poursaid A, Jolley MA, Saarel E, Triedman J, MacLeod RS. Measuring defibrillator surface potentials: The validation of a predictive defibrillation computer model. Comput Biol Med 2018; 102:402-410. [PMID: 30195579 DOI: 10.1016/j.compbiomed.2018.08.025] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2018] [Revised: 08/24/2018] [Accepted: 08/24/2018] [Indexed: 01/26/2023]
Abstract
Implantable cardioverter defibrillators (ICDs) are commonly used to reduce the risk in patients with life-threatening arrhythmias, however, clinicians have little systematic guidance to place the device, especially in cases of unusual anatomy. We have previously developed a computational model that evaluates the efficacy of a delivered shock as a clinical and research aid to guide ICD placement on a patient specific basis. We report here on progress to validate this model with measured ICD surface potential maps from patients undergoing ICD implantation and testing for defibrillation threshold (DFT). We obtained body surface potential maps of the defibrillation pulses by adapting a limited lead selection and potential estimation algorithm to deal with the limited space for recording electrodes. Comparison of the simulated and measured potential maps of the defibrillation shock yielded similar patterns, a typical correlation greater than 0.9, and a relative error less than 15%. Comparison of defibrillation thresholds also showed accurate prediction of the simulations. The high agreement of the potential maps and DFTs suggests that the predictive simulation generates realistic potential values and can accurately predict DFTs in patients. These validation results pave the way for use of this model in optimization studies prior to device implantation.
Collapse
Affiliation(s)
- Jess Tate
- Department of Bioengineering, University of Utah, Salt Lake City, USA; Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, USA.
| | - Jeroen Stinstra
- Department of Bioengineering, University of Utah, Salt Lake City, USA; Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, USA
| | - Thomas Pilcher
- Division of Pediatric Cardiology, University of Utah, Salt Lake City, USA
| | - Ahrash Poursaid
- Department of Bioengineering, University of Utah, Salt Lake City, USA; Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, USA
| | - Matthew A Jolley
- Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, USA
| | - Elizabeth Saarel
- Division of Pediatric Cardiology, University of Utah, Salt Lake City, USA
| | - John Triedman
- Department of Cardiology, Children's Hospital Boston, Boston, Massachusetts, USA
| | - Rob S MacLeod
- Department of Bioengineering, University of Utah, Salt Lake City, USA; Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, USA
| |
Collapse
|
2
|
Abstract
Advances in computer power, novel diagnostic and therapeutic medical technologies, and an increasing knowledge of pathophysiology from gene to organ systems make it increasingly feasible to apply multiscale patient-specific modeling based on proven disease mechanisms. Such models may guide and predict the response to therapy in many areas of medicine. This is an exciting and relatively new approach, for which efficient methods and computational tools are of the utmost importance. Investigators have designed patient-specific models in almost all areas of human physiology. Not only will these models be useful in clinical settings to predict and optimize the outcome from surgery and non-interventional therapy, but they will also provide pathophysiologic insights from the cellular level to the organ system level. Models, therefore, will provide insight as to why specific interventions succeed or fail.
Collapse
|